Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Associate Professor, New York College of Podiatric Medicine, United States

Dr. Paramita Basu is a distinguished scientist and educator specializing in infectious diseases, pharmaceutical sciences, and microbiology. Currently, she serves as an Associate Professor and Director of Infectious Diseases at the New York College of Podiatric Medicine and an Associate Professor of Pharmaceutical & Biomedical Sciences at Touro College of Pharmacy, New York. With a Ph.D. in Biological Sciences from St. John’s University, she has made significant contributions to research on biofilms, antibiotic resistance, and innovative learning methodologies. As a dedicated academic leader, she also chairs the Curriculum Committee at Touro College of Pharmacy, shaping the future of pharmaceutical education.

Publication Profile

🎓 Education

Dr. Basu earned her Ph.D. in Biological Sciences from St. John’s University, Queens, New York (2003-2008). Her research during this period focused on microbial resistance and biofilm control mechanisms, laying the foundation for her impactful work in microbiology and pharmaceutical sciences.

💼 Experience

With over a decade of experience in academia, Dr. Basu has held key positions in medical and pharmaceutical education. Since 2009, she has been an Associate Professor at Touro College of Pharmacy, where she teaches pharmaceutical and biomedical sciences. In 2022, she joined the New York College of Podiatric Medicine as the Director of Infectious Diseases, focusing on pre-clinical sciences and microbiology. Her expertise extends to curriculum development, interdisciplinary education, and research on antibiotic resistance in clinical settings.

🏆 Awards and Honors

Dr. Basu has received multiple recognitions for her outstanding research and academic contributions. She has been acknowledged for her pioneering work in antimicrobial resistance, biofilm studies, and the integration of audiovisual learning in medical education. Her research has been published in top-tier scientific journals, reflecting her impact on global microbiology and pharmaceutical sciences.

🔬 Research Focus

Dr. Basu’s research interests revolve around biofilm formation, antibiotic resistance mechanisms, and innovative drug therapies. Her work has significantly contributed to understanding Pseudomonas aeruginosa biofilms, Vibrio gazogenes interactions, and novel antibiotic treatments. Additionally, she explores the role of multimedia learning tools in medical education, aiming to improve student engagement and knowledge retention in pharmaceutical sciences.

🔎 Conclusion

Dr. Paramita Basu is a renowned microbiologist, educator, and researcher with a passion for antimicrobial resistance and innovative learning in pharmaceutical sciences. Her groundbreaking work in infectious disease research and medical education has solidified her position as a leader in the field. With a commitment to scientific advancement and student success, she continues to make a significant impact in pharmaceutical and biomedical sciences. 🚀

📚 Publications

Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review – Acta Microbiologica Hellenica (2025) [🔗DOI: 10.3390/amh70010009]

Integration of an Audiovisual Learning Resource in a Podiatric Medical Infectious Disease Course: Multiple Cohort Pilot Study – JMIR Medical Education (2025) [🔗DOI: 10.2196/55206]

Study of the impact of introducing a multimedia learning tool in podiatric medical courses – Journal of Foot and Ankle Research (2024) [🔗DOI: 10.1002/jfa2.12018]

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance – Journal of Experimental Biology and Agricultural Sciences (2024) [🔗DOI: 10.18006/2024.12(2).274.283]

Vibrio gazogenes-dependent disruption of aflatoxin biosynthesis in Aspergillus flavus – Frontiers in Microbiology (2023) [🔗DOI: 10.3389/fmicb.2023.1208961]

The Effect of Antibiotic Treatment and Gene Expression of Mex B Efflux Transporters on the Resistance in Pseudomonas Aeruginosa Biofilms – Applied Microbiology (2023) [🔗DOI: 10.3390/applmicrobiol3030049]

Surveillance of SARS-CoV-2 RNA in open-water sewage canals – Access Microbiology (2022) [🔗DOI: 10.1099/acmi.0.000318]

Antimicrobial Resistance in Pseudomonas aeruginosa Biofilms – Journal of Pure and Applied Microbiology (2021) [🔗DOI: 10.22207/JPAM.15.4.79]

Juan Valdivieso | Health Sciences | Best Researcher Award

Posted on by sciencefather

Mr. Juan Valdivieso | Health Sciences | Best Researcher Award

Research Lead, Savana, Spain

Dr. Juan Valdivieso is a distinguished medical professional specializing in immunology and oncology. He completed his medical degree in Ecuador and furthered his education in Spain, where he gained expertise in immuno-oncology. With extensive experience in both clinical practice and research, Dr. Valdivieso is currently a Medical Research Lead at SavanaResearch, Madrid. His work, particularly in the areas of rheumatoid arthritis and CAR-T cell monitoring, has been published in renowned scientific journals.

Publication Profile

Scopus

Strengths for the Award:

  1. Extensive Research Background: Dr. Juan Luis Valdivieso Shephard has a strong research background, with several publications in prestigious journals like Rheumatology (Oxford) and Heliyon. His work covers critical areas such as immunology, oncology, and artificial intelligence in medical research.
  2. Diverse Clinical Experience: He has gained significant clinical experience through his residency in immunology, rotations in oncology, and work as a medical researcher. This practical experience complements his research, making his contributions valuable in both clinical and research settings.
  3. Active in Scientific Community: Dr. Valdivieso Shephard has actively participated in various national and international conferences, presenting his research findings. His involvement in these events highlights his commitment to advancing his field and sharing knowledge with the broader scientific community.
  4. Collaborative Researcher: He has collaborated with various experts, contributing to multi-author publications and book chapters. This ability to work in a team and contribute to significant scientific literature is a strong point in his favor.
  5. Language Proficiency: Proficiency in both Spanish and English enables him to engage with a broader audience, increasing the impact of his research internationally.

Areas for Improvement:

  1. Further Specialization: While Dr. Valdivieso Shephard has a broad research portfolio, focusing more deeply on a specific niche within immunology or oncology could enhance his expertise and make him a leading figure in that area.
  2. Leadership Roles: Taking on more leadership roles in research projects or professional organizations could strengthen his profile. Mentoring junior researchers and leading large-scale studies would further demonstrate his capabilities.
  3. Grant Acquisition: Securing more research grants and funding would not only boost his research endeavors but also underscore his ability to attract resources, a key criterion for many research awards.

Education 🎓

Dr. Valdivieso earned his medical degree from the University of Cuenca, Ecuador, in 2013. He later obtained the Spanish equivalency of his medical degree in 2016. He completed a residency in immunology at Hospital Universitario La Paz in Madrid, Spain, from 2017 to 2021, followed by a master’s degree in Immuno-Oncology from Universidad Rey Juan Carlos, which he completed in 2023.

Experience 🏥

Dr. Valdivieso’s career began in Ecuador, where he served as a rural physician and later as an Onco-hematology doctor at Hospital José Carrasco Arteaga. Since 2021, he has been the Medical Research Lead at SavanaResearch in Madrid, Spain. His professional background also includes occasional teaching roles at MIR MediPlus.

Research Focus 🔬

Dr. Valdivieso’s research primarily focuses on immunology, oncology, and the application of artificial intelligence in medical research. His notable projects include studying anti-TNF treatment responses in rheumatoid arthritis and standardizing CAR-T cell monitoring techniques.

Awards and Honors 🏅

Throughout his career, Dr. Valdivieso has received recognition for his contributions to medical research, particularly in the field of immunology. His work has been cited in numerous scientific publications, reflecting the impact of his research on the medical community.

Publication Top Notes 📚

“Colitis expands the phenotype of PAAND patients: new case report and review of the literature” – Rheumatology (Oxford), 2021
Cited by 5 articles

“Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development” – Rheumatology, 2021
Cited by 7 articles

“Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature” – Clinical Immunology, 2021
Cited by 4 articles

“Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters” – Heliyon, 2024
Cited by 3 articles

“The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR technique” – Cytometry Part A, 2024
Cited by 2 articles

Conclusion:

Dr. Juan Luis Valdivieso Shephard is a strong candidate for the Best Researcher Award, given his extensive research experience, active participation in the scientific community, and contributions to immunology and oncology. His strengths, particularly in research and collaboration, make him a worthy contender. However, focusing on further specialization and leadership in research could enhance his candidacy for future awards.